Anti-psoriatic therapies and cardiovascular risk: is there a difference between different systemic agents?

K. Kridin; A. D. Cohen

doi:10.1111/jdv.16345

Anti-psoriatic therapies and cardiovascular risk: is there a difference between different systemic agents?

K. Kridin, A. D. Cohen

Research output: Contribution to journal › Comment/Debate

Original language	English
Pages (from-to)	668-669
Number of pages	2
Journal	Journal of the European Academy of Dermatology and Venereology
Volume	34
Issue number	4
DOIs	https://doi.org/10.1111/jdv.16345
State	Published - 1 Apr 2020
Externally published	Yes

ASJC Scopus subject areas

Dermatology
Infectious Diseases

Access to Document

10.1111/jdv.16345

Cite this

@article{5cf8324068eb4609a10c118a9142db3d,

title = "Anti-psoriatic therapies and cardiovascular risk: is there a difference between different systemic agents?",

author = "K. Kridin and Cohen, \{A. D.\}",

year = "2020",

month = apr,

day = "1",

doi = "10.1111/jdv.16345",

language = "English",

volume = "34",

pages = "668--669",

journal = "Journal of the European Academy of Dermatology and Venereology",

issn = "0926-9959",

publisher = "John Wiley and Sons Inc.",

number = "4",

}

TY - JOUR

T1 - Anti-psoriatic therapies and cardiovascular risk

T2 - is there a difference between different systemic agents?

AU - Kridin, K.

AU - Cohen, A. D.

PY - 2020/4/1

Y1 - 2020/4/1

UR - https://www.scopus.com/pages/publications/85082484365

U2 - 10.1111/jdv.16345

DO - 10.1111/jdv.16345

M3 - Comment/Debate

C2 - 32227423

AN - SCOPUS:85082484365

SN - 0926-9959

VL - 34

SP - 668

EP - 669

JO - Journal of the European Academy of Dermatology and Venereology

JF - Journal of the European Academy of Dermatology and Venereology

IS - 4

ER -

Anti-psoriatic therapies and cardiovascular risk: is there a difference between different systemic agents?

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this